Determining Health Insurance Coverage of Technology
Problems and Options
Bibliographic Data
| ID | 9102785 |
|---|---|
| Authors | Barbara Greenberg (0000-0002-4014-3685, Washington Center, corresponding author), Robert A Derzon |
| Year | 1981 |
| Volume | 19 |
| Issue | 10 |
| Pages | 967-978 |
| Publication date | 1981-10-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/00005650-198110000-00001 |
| PMID | 6796788 |
| OpenAlex | W2025893901 |
| Language | EN |
| Citations received | 2 |
| References cited | 1 |
By deciding which medical procedures are eligible for reimbursement, health insurance programs possess the potential to affect significantly technology use and health care spending. Traditionally, insurers have adopted a passive stance and made relatively few negative coverage determinations. However, resistance to rapidly rising costs has created a powerful inducement for third-party payors to become more prudent purchasers of health care services. Consequently, both Medicare and Blue Cross--Blue Shield are considering the implementation of changes that may ultimately result in more restrictive coverage decisions. This article examines the coverage process of Medicare and Blue Cross--Blue Shield and the policy changes that both programs are considering. In addition, it discusses the strengths and drawbacks of four coverage policy options: restricting insurance coverage of unproven procedures, introducing cost-effectiveness criteria, educating physicians and educating consumers
Actuarial science · Business · Economic growth · Economics · Health care · Health insurance · Risk analysis (engineering) · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management · Pharmaceutical Economics and Policy
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,07 |
| Citation span | 1997 - 2026 (30) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |